Immunai, a pioneering startup dedicated to constructing a comprehensive foundation model of the human immune system, has significantly deepened its…
Read More
Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced a significant expansion…
Read More
Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its oncology…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Immunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical Pipeline
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read More
Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…
Read More
AstraZeneca’s Targeted Treatment Offers New Hope for Stomach Cancer Patients in the UK
AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More
UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension
The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…
Read MoreYOU MAY HAVE MISSED
